HLA-DM

HLA-DM is a protein complex involved in the immune system of humans. It plays a crucial role in the antigen presentation process, which is essential for the activation of T cells and the subsequent immune response. HLA-DM is part of the major histocompatibility complex (MHC) class II molecules and is encoded by the HLA-DM gene.
Structure[edit]
HLA-DM is a heterodimer composed of two subunits: the alpha (α) chain and the beta (β) chain. These subunits are encoded by the HLA-DMA and HLA-DMB genes, respectively. The protein complex is located within the endosomal and lysosomal compartments of antigen-presenting cells (APCs) such as dendritic cells, macrophages, and B cells.
Function[edit]
The primary function of HLA-DM is to facilitate the loading of antigenic peptides onto MHC class II molecules. This process occurs within the acidic environment of the endosomal/lysosomal compartments. HLA-DM interacts with the MHC class II molecules, stabilizing them and promoting the release of the invariant chain-derived peptide, known as CLIP (Class II-associated invariant chain peptide). This allows for the binding of high-affinity antigenic peptides to the MHC class II molecules, which are then transported to the cell surface for recognition by CD4+ T cells.
Mechanism[edit]
HLA-DM functions by catalyzing the exchange of CLIP for antigenic peptides. It acts as a molecular chaperone, ensuring that only peptides with high affinity for the MHC class II binding groove are presented on the cell surface. This selective process is critical for the accurate presentation of antigens and the activation of the adaptive immune response.
Clinical Significance[edit]
Mutations or deficiencies in HLA-DM can lead to impaired antigen presentation and are associated with various autoimmune diseases and immunodeficiency disorders. Understanding the role of HLA-DM in these conditions can provide insights into potential therapeutic targets for modulating immune responses.
Research[edit]
Ongoing research is focused on elucidating the detailed mechanisms of HLA-DM function and its interactions with other components of the antigen presentation pathway. Studies are also exploring the potential of targeting HLA-DM in vaccine development and immunotherapy.
See also[edit]
- Major histocompatibility complex
- Antigen presentation
- T cell
- B cell
- Dendritic cell
- Macrophage
- Autoimmune disease
- Immunodeficiency
References[edit]
External links[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian